UHS Universal Health Services, Inc. Common Stock
NYSE · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 7, 2026UHS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
UHS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 16 Aralık 2009 | 2-for-1 | İleri |
| 04 Haziran 2001 | 2-for-1 | İleri |
| 20 Mayıs 1996 | 2-for-1 | İleri |
| 05 Temmuz 1983 | 2-for-1 | İleri |
Universal Health Services, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.
Company history
Alan B. Miller, who currently serves as the company's Executive Chairman, founded Universal Health Services, Inc. in 1979. Within 18 months of its founding, UHS owned four hospitals and had management contracts with two additional hospitals.
In 1979, UHS entered Las Vegas with the purchase of Valley Hospital.
In 1980, the company chose its first Board of Directors. In 1981, UHS held its initial public offering. In 1982, UHS purchased five hospitals from the Stewards Foundation, marking the first time a for-profit corporation purchased hospitals from a nonprofit religious organization. In 1983, UHS purchased Qualicare, Inc. for more than $116 million. The purchase included 11 acute care hospitals and four behavioral health hospitals. In 1986, UHS created Universal Health Realty Income Trust, the first REIT in the healthcare industry.
In 1991, UHS stock trading moved from NASDAQ to NYSE.
In November 2010, UHS reached an agreement in May to acquire Psychiatric Solutions, Inc. for $3.1 billion. In June 2012, UHS announced its plans to acquire Ascend Health Corporation for $517 million. In February 2014, UHS bought Palo Verde Mental Health for an undisclosed amount, renaming the facility to Palo Verde Behavioral Health. In April of that year, UHS announced the acquisition of the Psychiatric Institute of Washington. In September of that year, UHS' stock joined the S&P 500 Index and acquired Cygnet Health Care Limited for approximately $335 million. In August 2015, UHS acquired Alpha Hospitals Holdings Limited for $148 million from private equity group C&C Alpha Group. In September of that year, UHS announced the acquisition of Foundations Recovery Network based in Brentwood, Tennessee for $350 million. In August 2016, UHS bought Desert View Hospital in Pahrump, Nevada for an undisclosed amount. In December of that year, UHS acquired Cambian Group PLC's Adult Services Division. In July 2018, UHS announced its acquisition of the Danshell Group.
On September 28, 2020, Universal Health Services Inc. announced that its network went offline after an unspecified "IT security issue".
In September 2020, consistent with the company's long-standing succession plan, UHS announced that Alan B. Miller would step down as CEO in January 2021 and that President Marc D. Miller would be named CEO.
UHS ranked on the Fortune 500 in 2021, 2022 in 2023 and 2024, and 2025
UHS was named on the Fortune World's Most Admired List in 2025, 2024 2023, 2022, 2021 and 2020.
UHS has been named on the Forbes Global 2000 ranking in 2025. UHS is ranked at #1,090. Of the American companies on the ranking, UHS ranked #355 among U.S. companies and #23 among global Health Care Equipment and Services category. UHS has been on the ranking for 22 years, and in 2023 earned ‘Hall of Fame’ status.
In March 2026, UHS agreed to acquire online and mobile therapy service provider Talkspace for $835 million.
Controversies
Hospital licenses
The Centers for Medicare and Medicaid Services (CMS) threatened the Rancho Springs Medical Center (Murrieta) and Inland Valley Regional Medical Center (Wildomar) in California with decertification in June 2010 while the State of California warned of a possible hospital license revocation. Universal Health Services implemented a program to address all concerns and in November 2011 the two hospitals passed a CMS Certification Survey. As a result, CMS rescinded its termination notice and the California Department of Public Health withdrew its license revocation notice.
Allegations of noncompliance with same-sex visitation law
According to a petition started on Change.org by Terri-Ann Simonelli of Henderson, Nevada, Spring Valley Hospital (owned and operated by UHS) claimed that their policy required power of attorney for a same-sex partner to make medical decisions on behalf of their partner. If true, this would seemingly violate new Department of Health and Human Services rules enabling same-sex partners to make said decisions, with or without power of attorney.
Fraudulent Medicaid claims
In September 2012, UHS and its subsidiaries, Keystone Education and Youth Services LLC and Keystone Marion LLC d/b/a Keystone Marion Youth Center agreed to pay over $6.9 million to resolve allegations that they submitted false and fraudulent claims to Medicaid. Between October 2004 and March 2010, the entities allegedly provided substandard psychiatric counseling and treatment to adolescents in violation of the Medicaid requirements. The United States alleged that UHS falsely represented Keystone Marion Youth Center as a residential treatment facility providing inpatient psychiatric services to Medicaid enrolled children, when in fact it was a juvenile detention facility. The United States further alleged that neither a medical director nor licensed psychiatrist provided the required direction for psychiatric services or for the development of initial or continuing treatment plans. The settlement further resolved allegations that the entities filed false records or statements to Medicaid when they filed treatment plans that falsely represented the level of services that would be provided to the patients.
On July 10, 2020, the US Department of Justice announced a $122 million Fraudulent Claims case with "Universal Health Services, Inc., UHS of Delaware, Inc.(together, UHS), and Turning Point Care Center, LLC (Turning Point), a UHS facility located in Moultrie, Georgia, have agreed to pay a combined total of $122 million to resolve alleged violations of the False Claims Act for billing for medically unnecessary inpatient behavioral health services, failing to provide adequate and appropriate services, and paying illegal inducements to federal healthcare beneficiaries." From the announcement: "The government alleged that, between January 2006, and December 2018, UHS's facilities admitted federal healthcare beneficiaries who were not eligible for inpatient or residential treatment because their conditions did not require that level of care, while also failing to properly discharge appropriately admitted beneficiaries when they no longer required inpatient care. The government further alleged that UHS's facilities billed for services not rendered, billed for improper and excessive lengths of stay, failed to provide adequate staffing, training, and/or supervision of staff, and improperly used physical and chemical restraints and seclusion. In addition, UHS's facilities allegedly failed to develop and/or update individual assessments and treatment plans for patients, failed to provide adequate discharge planning, and failed to provide required individual and group therapy services in accordance with federal and state regulations.
Of the $117 million to be paid by UHS to resolve these claims, the federal government will receive a total of $88,124,761.27, and a total of $28,875,238.73 will be returned to individual states, which jointly fund state Medicaid programs."
BuzzFeed investigation
On December 7, 2016, BuzzFeed published a report detailing questionable practices within UHS psychiatric facilities. The report includes allegations of holding nonthreatening patients against their will, manipulative misinterpretation of patient testimonies to fit guidelines to involuntary confinement, aggressive staff layoffs and understaffing in hospitals, needless patient deaths due to understaffing and misprescription of medication, "violating a patient's right to be discharged or holding a patient without the proper documentation", and unnecessary extension of stay times to the maximum Medicare payout. UHS denied the conclusions of the report. UHS stock fell approximately 12% after publication.
According to BuzzFeed investigative reporter Rosalind Adams, UHS responded to the report by hiring "a global PR firm that offers specialized crisis management services... UHS didn't just implement a crisis PR plan. It also fired an employee that the company believed to have spoken to a reporter; it sued a former employee it alleges leaked damaging internal surveillance videos; it threatened to sue other employees; at least one facility held a series of town hall meetings to warn employees from speaking with us; it conducted "in-depth interviews" with nearly two dozen staff, then distributed a public apology that two of them signed; it enlisted one of the most powerful law firms in the United States; it built multiple, high-production-value websites specifically designed to overcome the reputational damage that our reporting might cause."
Cygnet Healthcare
A UK subsidiary, Cygnet Health Care, was the subject of a BBC investigation that found that staff had been taunting, provoking and scaring vulnerable people. It runs 140 mental health services across the UK. 85% of its services are "rated good or outstanding by our regulators". New admissions were banned at Cygnet Acer clinic after the Care Quality Commission found it unsafe to use. A patient hanged herself, others self harmed, ligature points were found where patients could hang themselves and too many of the staff were untrained to deal with the highly vulnerable patients at the clinic.
The company bought four inpatient units which were previously operated by the Danshell Group in 2018. All four were condemned by the Care Quality Commission which raised concerns about patients' "unexplained injuries" and high levels of restraint in 2019.
Laurel Oaks Behavior Health Center
On February 8, 2024, a lawsuit was filed against the company's Dothan, Alabama-based Laurel Oaks Behavioral Health Center and its CEO Janette Jackson which alleged that Laurel Oaks Behavior Health Center mishandled numerous incidents involving the assault of an eight-year-old boy residing in the facility. The boy was reportedly assaulted by his larger roommate while he residing at the facility for a week in 2022. Universal Health Services would be sued as well. The lawsuit also noted that a 40-year-old man was convicted in 2011 of sexually assaulting a teenage patient while employed at Laurel Oaks. A 17-year-old patient had been charged in 2014 with felony counts of first-degree sodomy as well.
Provo Canyon School
Provo Canyon School was the name two residential treatment centers operated by UHS before being shutdown by the Utah DHHS. The school was in media headlines for years as abuse was prominent throughout its history, including past owners. To name a few allegations, "using a cruel, unusual, or unnecessary practice on a child by withholding personal interaction, emotional response, or stimulation", and "depriving [children] (cilents) of water, rest, and the opportunity for toileting."
Additional allegations
On May 16, 2021, Detroit Free Press published an article alleging UHS partner St. Simons By The Sea (formerly Focus By The Sea) in St. Simons Island, Georgia recruited patients from a local soup kitchen for treatment that may have been coercive or medically unnecessary.(subscription required)
Facilities
Hospitals and medical centers
As of June 2024, the UCS website lists the following medical and acute care facilities in the United States.
California
Corona
Southwest Healthcare Corona Regional Medical Center
Murrieta
A Plus Urgent Care
Southwest Healthcare Rancho Springs Hospital
Temecula Valley Day Surgery
Palmdale
Southwest Healthcare Palmdale Regional Medical Center
Riverside
Riverside Medical Clinic
Temecula
Southwest Healthcare Temecula Valley Hospital
Wildomar
Southwest Healthcare Inland Valley Hospital
District of Columbia
Washington
The George Washington University Hospital
Cedar Hill Hospital Medical Center
Florida
Arcadia
Manatee Diagnostic Center (Arcadia)
Bradenton
ER at Bayshore Gardens
ER at Sun City Center
ER at Palma Sola
Lakewood Ranch Medical Center
Lakewood Ranch Medical Group
Manatee Diagnostic Center (Pointe West)
Manatee Diagnostic Center (Riverside)
Manatee Health
Manatee Memorial Hospital
Manatee Physician Alliance
Orlando
University Behaviorial Center
Parrish
Manatee Diagnostic Center (Parrish)
Royal Palm Beach
Palms Westside Clinic ASC
Sarasota
ER at Fruitville
Wellington
Wellington Physicians Alliance
West Palm Beach
Wellington Regional Medical Center
Westlake
ER at Westlake
Wimauma
ER at Sun City Center
Nevada
Henderson
ER at Green Valley Ranch
Henderson Hospital
Las Vegas
Centennial Hills Hospital Medical Center
Elite Medical Center
ER at Blue Diamond
ER at Desert Springs
ER at West Craig Road
Spring Valley Hospital Medical Center
Summerlin Hospital Medical Center
Valley Health Physician Alliance
Valley Health Specialty Hospital
Valley Hospital Medical Center
North Las Vegas
ER at North Las Vegas
ER at Valley Vista
Pahrump
Desert View Hospital
Reno
ER at Damonte Ranch
ER at McCarran NW
Northern Nevada Sierra Medical Center
Quail Surgical and Pain Management Center
Sparks
ER at Spanish Springs
Northern Nevada Medical Center
Northern Nevada Medical Group
Oklahoma
Enid
St. Mary's Physician Associates
St. Mary's Regional Medical Center
Pennsylvania
King of Prussia
Eastern Pennsylvania Physician Alliance
UHS Corporate
South Carolina
Aiken
Aiken Physicians Alliance
Aiken Regional Medical Centers
Cancer Care Institute of Carolina
The Surgery Center of Aiken
North Augusta
ER at Sweetwater
Texas
Alamo
South Texas Health System ER Alamo
Amarillo
Northwest Emergency at Town Square
Northwest Emergency on Georgia
Northwest Physicians Group
Northwest Texas Healthcare System
Anna
ER at Anna
Bonham
TMC Bonham Hospital
Denison
Texoma Medical Center
TexomaCare
Eagle Pass
Fort Duncan Regional Medical Center
Edinburg
Cornerstone Regional Hospital
South Texas Health System Edinburg / South Texas Health System Children's
South Texas Health System ER McColl
South Texas Health System ER Monte Cristo
Laredo
Doctors Hospital Emergency Room Saunders
Doctors Hospital Emergency Room South
Doctors Hospital of Laredo
Laredo Physicians Group
McAllen
South Texas Health System Clinics
South Texas Health System ER Ware Road
South Texas Health System Heart
South Texas Health System McAllen
Mission
South Texas Health System ER Mission
Sherman
ER at Sherman
Weslaco
South Texas Health System ER Weslaco
Behavioral health facilities
UHS also operates over 300 behavioral health facilities in the United States and the United Kingdom, including:
Cygnet Health Care, UK
Psychiatric Institute of Washington, Washington, District of Columbia
Suncoast Behavioral Health Center, Bradenton, Florida
Fuller Hospital, South Attleboro, Massachusetts
Willow Springs Center, Reno, Nevada
Friends Hospital, Philadelphia, Pennsylvania
Provo Canyon School, Provo, Utah
Lancaster Behavioral Health Hospital, Lancaster, PA
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | UHS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 7.25Y ort. ≈11.7 | ≈11.7 | 16.5 | Düşük değerli | |
| PEG Ratio (PEG Oranı) | ≈0.4 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | UHS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | 11.4%5Y ort. ≈10.1% | ≈10.1% | 11.9% | Zayıf | |
| EBITDA Margin (FAVÖK Marjı) | 11.5%5Y ort. ≈10.1% | ≈10.1% | 11.1% | Aynı seviyede | |
| Vergi Öncesi Kar Marjı (TTM) | 11.2%5Y ort. ≈9.1% | ≈9.1% | 9.8% | Aynı seviyede | |
| Net Kâr Marjı (TTM) | 8.4%5Y ort. ≈6.9% | ≈6.9% | 7.3% | Aynı seviyede | |
| ROA (TTM) | 9.9%5Y ort. ≈7.7% | ≈7.7% | 6.5% | En üst düzey | |
| ROE (TTM) | 21.0%5Y ort. ≈17.0% | ≈17.0% | 19.1% | Aynı seviyede | |
| ROIC | 12.7%5Y ort. ≈10.8% | ≈10.8% | 13.5% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | UHS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.65Y ort. ≈0.7 | ≈0.7 | 0.2 | Yüksek borç | |
| Cari Oran (MRQ) | 1.15Y ort. ≈1.2 | ≈1.2 | 1.2 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 0.85Y ort. ≈1.0 | ≈1.0 | 0.9 | Aynı seviyede | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 0.55Y ort. ≈0.7 | ≈0.7 | 0.2 | Yüksek borç | |
| Interest Coverage (Faiz Karşılama Oranı) | 12.85Y ort. ≈9.2 | ≈9.2 | 7.8 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | UHS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 9.7%5Y ort. ≈9.0% | ≈9.0% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 9.0%5Y ort. ≈8.0% | ≈8.0% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 8.5% | · | · | · | |
| EPS YoY (EPS YB) | 37.3%5Y ort. ≈37.9% | ≈37.9% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | 30.4%5Y ort. ≈31.9% | ≈31.9% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 36.2%5Y ort. ≈15.4% | ≈15.4% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | 16.0% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | 30.1%5Y ort. ≈8.7% | ≈8.7% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | 9.5% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | UHS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 1.25Y ort. ≈1.1 | ≈1.1 | 0.8 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 7.35Y ort. ≈7.0 | ≈7.0 | 8.4 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$170.2K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Eyl 1, 2026 | $0,20 | USD | ≈0.47% |
| Haz 8, 2026 | $0,20 | USD | ≈0.56% |
| Mar 2, 2026 | $0,20 | USD | ≈0.39% |
| Ara 1, 2025 | $0,20 | USD | ≈0.33% |
| Eyl 2, 2025 | $0,20 | USD | ≈0.44% |
| Haz 2, 2025 | $0,20 | USD | ≈0.43% |
| Mar 3, 2025 | $0,20 | USD | ≈0.46% |
| Ara 3, 2024 | $0,20 | USD | ≈0.40% |
| Eyl 3, 2024 | $0,20 | USD | ≈0.34% |
| Haz 3, 2024 | $0,20 | USD | ≈0.43% |
| Şub 29, 2024 | $0,20 | USD | ≈0.48% |
| Kas 30, 2023 | $0,20 | USD | ≈0.58% |
| Ağu 31, 2023 | $0,20 | USD | ≈0.59% |
| May 31, 2023 | $0,20 | USD | ≈0.61% |
| Şub 28, 2023 | $0,20 | USD | ≈0.60% |
| Kas 30, 2022 | $0,20 | USD | ≈0.61% |
| Ağu 31, 2022 | $0,20 | USD | ≈0.82% |
| May 31, 2022 | $0,20 | USD | ≈0.64% |
| Şub 28, 2022 | $0,20 | USD | ≈0.56% |
| Kas 30, 2021 | $0,20 | USD | ≈0.67% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Tem 27, 2026 | $5.98 | $6.02 | -0.61% |
| 31 Mart 2026 | $5.62 | $5.46 | 2.9% | |
| 31 Aralık 2025 | $5.88 | $5.96 | -1.3% | |
| 30 Eylül 2025 | $5.69 | $4.88 | 16.5% | |
| 30 Haziran 2025 | $5.35 | $4.97 | 7.6% | |
| 31 Mart 2025 | $4.84 | $4.39 | 10.2% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | |
| Operating Expenses | $15.37B | $14.15B | $13.11B | $12.40B | $11.28B | $10.20B | $10.16B | $9.60B | $9.13B | $8.48B | $7.78B | $7.14B | |
| Operating Income | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B | $1.26B | $1.06B | |
| Interest Expense | $156M | $186M | $207M | $127M | $84M | $106M | $163M | $155M | $145M | $125M | $113M | $134M | |
| Other Non-op | $134M | $2M | $-28M | $-10M | $14M | $14.0K | $13M | $14M | $0 | $0 | · | · | |
| Pretax Income | $1.97B | $1.50B | $940M | $866M | $1.29B | $1.25B | $1.07B | $1.03B | $1.14B | $1.16B | $1.15B | $930M | |
| Income Tax | $461M | $335M | $221M | $209M | $306M | $299M | $239M | $237M | $364M | $409M | $395M | $325M | |
| Net Income | $1.49B | $1.14B | $718M | $676M | $992M | $944M | $815M | $780M | $752M | $702M | $681M | $545M | |
| EPS (Basic) | $23.42 | $17.16 | $10.35 | $9.23 | $11.99 | $11.06 | $9.16 | $8.35 | $7.86 | $7.22 | $6.89 | $5.52 | |
| EPS (Diluted) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 | $6.76 | $5.42 | |
| Shares (Basic) | 63,581,000 | 66,554,000 | 69,321,000 | 73,118,000 | 82,519,000 | 85,061,000 | 88,762,000 | 93,276,000 | 95,652,000 | 97,208,000 | 98,797,000 | 98,826,000 | |
| Shares (Diluted) | 64,462,000 | 67,896,000 | 70,125,000 | 73,832,000 | 83,692,000 | 85,587,000 | 89,040,000 | 93,750,000 | 96,325,000 | 98,380,000 | 100,694,000 | 100,544,000 | |
| EBITDA | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B | $1.66B | $1.44B |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $138M | $126M | $119M | $103M | $115M | $1.22B | $61M | $105M | $74M | $34M | $61M | $32M | |
| Receivables | $2.60B | $2.18B | $2.24B | $2.02B | $1.75B | $1.73B | $1.56B | $1.51B | $1.50B | $1.44B | $1.30B | $1.28B | |
| Other Current Assets | $436M | $292M | $237M | $198M | $195M | $138M | $134M | $174M | $87M | $83M | $103M | $78M | |
| Current Assets | $3.41B | $2.82B | $2.81B | $2.54B | $2.26B | $3.28B | $1.92B | $1.94B | $1.80B | $1.68B | $1.72B | $1.62B | |
| PP&E (Net) | $7.01B | $6.57B | $6.12B | $5.92B | $5.87B | $5.37B | $5.02B | $4.85B | $4.57B | $4.33B | $3.84B | $3.68B | |
| PP&E (Gross) | $13.49B | $12.64B | $11.78B | $11.09B | $10.77B | $9.89B | $9.11B | $8.56B | $7.92B | $7.31B | $6.53B | $6.21B | |
| Accum. Depreciation | $6.48B | $6.07B | $5.65B | $5.17B | $4.90B | $4.51B | $4.09B | $3.72B | $3.35B | $2.98B | $2.69B | $2.53B | |
| Goodwill | $3.99B | $3.93B | $3.93B | $3.91B | $3.96B | $3.88B | $3.87B | $3.84B | $3.83B | $3.78B | $3.60B | $3.29B | |
| Intangibles | $76M | $76M | $77M | $78M | $81M | $83M | $84M | $173M | $220M | $228M | $219M | $98M | |
| Other Non-current Assets | $5.11B | $5.08B | $5.03B | $5.04B | $4.96B | $4.82B | $4.74B | $4.48B | $4.39B | $4.31B | $4.06B | $3.68B | |
| Total Assets | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B | $11.67B | $11.27B | $10.76B | $10.32B | $9.62B | $8.95B | |
| Accounts Payable | $750M | $632M | $614M | $637M | $659M | $571M | $447M | $446M | $442M | $440M | $366M | $336M | |
| Current Liabilities | $3.24B | $2.21B | $2.01B | $1.91B | $1.98B | $2.48B | $1.56B | $1.45B | $1.85B | $1.32B | $1.10B | $1.18B | |
| Capital Leases | $341M | $376M | $383M | $396M | $305M | $278M | $270M | $18M | $20M | $22M | $23M | · | |
| Deferred Tax | $6M | $0 | · | · | $0 | $6M | $25M | $50M | $55M | $88M | $316M | $168M | |
| Other Non-current Liabilities | $528M | $656M | $584M | $488M | $465M | $459M | $330M | $362M | $306M | $275M | $279M | $269M | |
| Long-term Debt | $4.80B | $4.50B | $4.91B | $4.81B | $4.19B | $3.86B | $3.98B | $4.00B | $4.04B | $4.14B | $3.43B | $3.28B | |
| Total Debt | $4.75B | $4.50B | $4.91B | $4.81B | $4.19B | $3.86B | $3.98B | $4.00B | $4.04B | $4.14B | $3.45B | $3.28B | |
| Retained Earnings | $7.99B | $7.37B | $6.80B | $6.53B | $6.60B | $6.75B | $5.93B | $5.79B | $5.35B | $4.89B | $4.57B | $4.02B | |
| AOCI | $48M | $7M | $9M | $-10M | $30M | $48M | $32M | $4M | $7M | $-25M | $-23M | $-25M | |
| Stockholders' Equity | $7.28B | $6.67B | $6.15B | $5.92B | $6.09B | $6.32B | $5.50B | $5.39B | $4.99B | $4.53B | $4.25B | $3.74B | |
| Liabilities + Equity | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B | $11.67B | $11.27B | $10.76B | $10.32B | $9.62B | $8.97B |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $619M | $585M | $568M | $582M | $533M | $510M | $490M | $453M | $448M | $417M | $399M | $376M | |
| Stock-based Comp | $96M | $99M | $88M | $85M | $74M | $66M | $69M | $67M | $57M | $48M | $40M | $31M | |
| Deferred Tax | $51M | $-33M | $-18M | $-18M | $-30M | $-27M | $-36M | $-10M | $-37M | $-10M | $-11M | $49M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | $-88M | $35M | |
| Operating Cash Flow | $1.86B | $2.07B | $1.27B | $996M | $884M | $2.36B | $1.44B | $1.27B | $1.25B | $1.33B | $1.07B | $1.04B | |
| CapEx | $1.02B | $944M | $743M | $734M | $856M | $731M | $634M | $665M | $558M | $520M | $379M | $391M | |
| Investing Cash Flow | $-1.07B | $-911M | $-763M | $-647M | $-914M | $-803M | $-688M | $-747M | $-685M | $-1.16B | $-913M | $-833M | |
| Net Debt Issued | $-44M | $-2.64B | $-85M | $-89M | $-3.04B | $-963M | $-57M | $-830M | $-143M | $-459M | $-68M | $-879M | |
| Stock Issued | $17M | $15M | $14M | $14M | $13M | $12M | $11M | $10M | $10M | $10M | $8M | $7M | |
| Stock Repurchased | $968M | $671M | $547M | $833M | $1.22B | $207M | $771M | $397M | $364M | $353M | $210M | $101M | |
| Net Stock Activity | $-951M | $-656M | $-534M | $-819M | $-1.21B | $-194M | $-760M | $-387M | $-354M | $-344M | $-201M | $-94M | |
| Dividends Paid | $51M | $53M | $55M | $58M | $66M | $17M | $53M | $37M | $38M | $39M | $40M | $30M | |
| Financing Cash Flow | $-750M | $-1.14B | $-494M | $-318M | $-1.07B | $-385M | $-845M | $-492M | $-519M | $-171M | $-125M | $-187M | |
| Net Change in Cash | $47M | $10M | $14M | $22M | $-1.10B | $1.17B | $-94M | $32M | $45M | $5M | $29M | $15M | |
| Taxes Paid | $471M | $325M | $258M | $251M | $363M | $286M | $261M | $294M | $371M | $345M | $381M | $259M | |
| Free Cash Flow | $849M | $1.12B | $525M | $262M | $28M | $1.63B | $804M | $676M | $625M | $769M | $642M | $645M | |
| Levered FCF | $730M | $979M | $367M | $166M | $-36M | $1.55B | $678M | $556M | $526M | $688M | $567M | $558M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% | 13.9% | 13.2% | |
| Net Margin | 8.6% | 7.2% | 5.0% | 5.0% | 7.8% | 8.2% | 7.2% | 7.2% | 7.2% | 7.2% | 7.5% | 6.8% | |
| Pretax Margin | 11.4% | 9.5% | 6.6% | 6.5% | 10.2% | 10.8% | 9.4% | 9.6% | 10.9% | 11.8% | 12.7% | 11.5% | |
| EBITDA Margin | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% | 18.3% | 17.8% | |
| ROA | 9.9% | 8.0% | 5.2% | 5.0% | 7.6% | 7.1% | 7.0% | 6.9% | 7.0% | 7.0% | 7.2% | 6.1% | |
| ROE | 21.4% | 17.8% | 11.9% | 11.2% | 16.0% | 16.0% | 15.0% | 15.0% | 15.8% | 16.0% | 17.0% | 15.6% | |
| ROIC | 12.7% | 11.7% | 8.1% | 7.1% | 10.1% | 10.2% | 10.0% | 9.7% | 9.6% | 9.6% | 10.7% | 9.9% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.3 | 1.4 | 1.3 | 1.1 | 1.3 | 1.2 | 1.3 | 1.0 | 1.3 | 1.6 | 1.4 | |
| Quick Ratio | 0.8 | 1.0 | 1.2 | 1.1 | 0.9 | 1.2 | 1.0 | 1.1 | 0.9 | 1.1 | 1.2 | 1.1 | |
| Debt / Equity | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 0.8 | 0.9 | |
| LT Debt / Equity | 0.6 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.9 | 0.8 | 0.9 | |
| Interest Coverage | 12.8 | 9.0 | 5.7 | 7.9 | 16.3 | 12.8 | 7.5 | 7.6 | 8.8 | 10.2 | 11.1 | 8.0 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.1 | 1.0 | 1.0 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.9 | |
| Receivables Turnover | 7.3 | 7.2 | 6.7 | 7.1 | 7.3 | 7.0 | 7.4 | 7.2 | 7.1 | 7.1 | 7.0 | 6.7 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $269.38 | $233.12 | $203.66 | $181.48 | $151.06 | $135.05 | $127.79 | $114.90 | $108.07 | $99.27 | $89.81 | $80.22 | |
| Cash Flow / Share | $28.92 | $30.45 | $18.08 | $13.49 | $10.56 | $27.58 | $16.16 | $14.30 | $12.28 | $13.10 | $10.14 | $10.30 | |
| Dividend Paid / Share | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | · | $0.60 | $0.40 | · | · | · | $0.30 | |
| EPS (TTM) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 | $6.76 | $5.42 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.7% | 10.8% | 6.6% | 6.0% | 9.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 9.0% | 7.8% | 7.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 37.3% | 64.4% | 11.9% | -22.7% | 7.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.2% | 12.5% | -2.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 16.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 30.4% | 59.1% | 6.2% | -31.9% | 5.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 30.1% | 4.8% | -8.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 24.2% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | |
| Net Income TTM | $1.49B | $1.14B | $718M | $676M | $992M | $944M | $815M | $780M | $752M | $702M | $681M | $545M | |
| P/E | 9.4 | 10.7 | 14.9 | 15.4 | 11.0 | 12.5 | 15.7 | 14.0 | 14.5 | 14.9 | 17.7 | 20.5 | |
| Earnings Yield | 10.6% | 9.4% | 6.7% | 6.5% | 9.1% | 8.0% | 6.4% | 7.1% | 6.9% | 6.7% | 5.7% | 4.9% | |
| Payout Ratio | 3.4% | 4.7% | 7.7% | 8.6% | 6.7% | 1.8% | 6.5% | 4.8% | 5.1% | 5.5% | 5.8% | 5.4% | |
| Annual Payout | $51M | $53M | $55M | $58M | $66M | $17M | $53M | $37M | $38M | $39M | $40M | $30M |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.64B | $4.50B | $4.49B | $4.50B | $4.28B | $4.10B | $4.11B | $3.96B | $3.91B | $3.84B | $3.70B | $3.56B | $3.55B | $3.47B | $3.45B | $3.34B | |
| Operating Expenses | $4.12B | $3.99B | $3.97B | $3.97B | $3.78B | $3.64B | $3.64B | $3.58B | $3.47B | $3.45B | $3.37B | $3.28B | $3.27B | $3.19B | $3.19B | $3.06B | |
| Operating Income | $517M | $503M | $517M | $522M | $500M | $455M | $472M | $384M | $436M | $389M | $331M | $285M | $280M | $279M | $261M | $276M | |
| Interest Expense | $40M | $37M | $42M | $38M | $35M | $40M | $40M | $45M | $49M | $53M | $54M | $53M | $49M | $51M | $44M | $36M | |
| Other Non-op | $2M | $3M | $106M | $14M | $8M | $6M | $6M | $2M | $-5M | $150.0K | $4M | $-11M | $-7M | $-14M | $5M | $-6M | |
| Pretax Income | $479M | $469M | $581M | $497M | $473M | $420M | $438M | $342M | $382M | $336M | $281M | $221M | $225M | $214M | $222M | $234M | |
| Income Tax | $115M | $110M | $134M | $118M | $111M | $99M | $101M | $76M | $88M | $70M | $62M | $52M | $55M | $52M | $52M | $57M | |
| Net Income | $358M | $349M | $446M | $373M | $353M | $317M | $332M | $259M | $289M | $262M | $216M | $167M | $171M | $163M | $175M | $183M | |
| EPS (Basic) | $6.01 | $5.71 | $7.14 | $5.92 | $5.49 | $4.87 | $5.05 | $3.89 | $4.32 | $3.90 | $3.18 | $2.42 | $2.44 | $2.31 | $2.44 | $2.52 | |
| EPS (Diluted) | $5.98 | $5.65 | $7.01 | $5.86 | $5.43 | $4.80 | $4.94 | $3.80 | $4.26 | $3.82 | $3.13 | $2.40 | $2.42 | $2.28 | $2.42 | $2.50 | |
| Shares (Basic) | 59,657,000 | 61,071,000 | · | 62,974,000 | 64,356,000 | 64,970,000 | · | 66,537,000 | 66,878,000 | 67,204,000 | · | 68,867,000 | 70,073,000 | 70,535,000 | · | 72,595,000 | |
| Shares (Diluted) | 59,910,000 | 61,668,000 | · | 63,663,000 | 64,991,000 | 66,037,000 | · | 68,108,000 | 67,920,000 | 68,482,000 | · | 69,624,000 | 70,839,000 | 71,487,000 | · | 73,060,000 | |
| EBITDA | $517M | $503M | · | $522M | $500M | $455M | · | $384M | $436M | $389M | · | $285M | $280M | $279M | · | $276M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $139M | $119M | $138M | $113M | $138M | $127M | $126M | $106M | $129M | $112M | $119M | $81M | $79M | $110M | $103M | $75M | |
| Receivables | $2.80B | $2.75B | $2.60B | $2.59B | $2.30B | $2.41B | $2.18B | $2.21B | $2.16B | $2.30B | · | $2.23B | $2.10B | $2.03B | · | $1.90B | |
| Other Current Assets | $505M | $406M | $436M | $333M | $327M | $317M | $292M | $262M | $236M | $243M | · | $223M | $226M | $201M | · | $262M | |
| Current Assets | $3.68B | $3.50B | $3.41B | $3.26B | $2.99B | $3.08B | $2.82B | $2.80B | $2.74B | $2.87B | · | $2.75B | $2.62B | $2.56B | · | $2.46B | |
| PP&E (Net) | $7.14B | $7.06B | $7.01B | $6.97B | $6.88B | $6.70B | $6.57B | $6.44B | $6.33B | $6.18B | · | $6.09B | $6.03B | $5.95B | · | $5.94B | |
| PP&E (Gross) | $13.83B | $13.61B | · | $13.45B | $13.24B | $12.91B | · | $12.45B | $12.24B | $11.96B | · | $11.61B | $11.44B | $11.25B | · | $11.10B | |
| Accum. Depreciation | $6.69B | $6.55B | $6.48B | $6.48B | $6.35B | $6.21B | $6.07B | $6.01B | $5.91B | $5.77B | · | $5.52B | $5.41B | $5.30B | · | $5.17B | |
| Goodwill | $3.98B | $3.98B | $3.99B | $3.99B | $3.98B | $3.95B | $3.93B | $3.97B | $3.94B | $3.93B | $3.93B | $3.91B | $3.93B | $3.91B | $3.91B | $3.87B | |
| Intangibles | · | · | $76M | · | · | · | $76M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | $5.11B | · | · | · | $5.08B | · | · | · | · | · | · | · | · | · | |
| Total Assets | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | · | $13.87B | $13.73B | $13.56B | · | $13.38B | |
| Accounts Payable | · | · | $750M | · | · | · | $632M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3.30B | $3.24B | $3.24B | $3.16B | $2.32B | $2.33B | $2.21B | $2.01B | $2.15B | $2.08B | · | $1.99B | $2.04B | $1.86B | · | $1.94B | |
| Capital Leases | $339M | $345M | $341M | $346M | $352M | $369M | $376M | $378M | $380M | $374M | · | $389M | $388M | $396M | · | $393M | |
| Deferred Tax | $3M | $3M | $6M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $560M | $533M | $528M | $590M | $629M | $682M | $656M | $660M | $570M | $551M | · | $588M | $571M | $532M | · | $500M | |
| Long-term Debt | $4.90B | $4.70B | $4.75B | $4.70B | $4.60B | $4.60B | $4.50B | $4.70B | $4.50B | $4.90B | · | $4.90B | $4.70B | $4.80B | · | $4.70B | |
| Total Debt | $4.85B | $4.71B | · | $4.69B | $4.58B | $4.65B | · | $4.66B | $4.54B | $4.86B | · | $4.92B | $4.72B | $4.80B | · | $4.70B | |
| Retained Earnings | · | · | $7.99B | · | · | · | $7.37B | · | · | · | · | · | · | · | · | · | |
| AOCI | · | · | $48M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $7.51B | $7.46B | $7.28B | $7.17B | $7.03B | $6.79B | $6.67B | $6.61B | $6.49B | $6.26B | · | $6.06B | $6.09B | $6.01B | · | $5.86B | |
| Liabilities + Equity | $15.94B | $15.68B | $15.53B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | · | $13.87B | $13.73B | $13.56B | · | $13.38B |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $167M | $155M | $163M | $155M | $152M | $148M | $147M | $150M | $147M | $141M | $145M | $137M | $144M | $142M | $148M | $146M | |
| Stock-based Comp | $23M | $23M | $25M | $25M | $24M | $22M | $27M | $27M | $27M | $20M | $22M | $23M | $22M | $21M | $23M | $21M | |
| Operating Cash Flow | $443M | $402M | $575M | $381M | $549M | $360M | $658M | $333M | $679M | $396M | $452M | $162M | $363M | $291M | $297M | $221M | |
| CapEx | $228M | $217M | $281M | $229M | $266M | $239M | $246M | $248M | $241M | $209M | $206M | $200M | $168M | $169M | $164M | $162M | |
| Investing Cash Flow | $-234M | $-198M | $-224M | $-269M | $-306M | $-271M | $-208M | $-266M | $-243M | $-195M | $-239M | $-176M | $-170M | $-178M | $-248M | $-73M | |
| Net Debt Issued | · | $-45M | · | · | · | $-9M | · | · | · | $-64M | · | · | · | $-16M | · | · | |
| Stock Issued | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $4M | $4M | |
| Stock Repurchased | $321M | $164M | $352M | $237M | $155M | $223M | $250M | $183M | $96M | $142M | $162M | $176M | $125M | $85M | $110M | $158M | |
| Net Stock Activity | · | $-160M | · | · | · | $-220M | · | · | · | $-139M | · | · | · | $-82M | · | · | |
| Dividends Paid | $12M | $13M | $12M | $12M | $13M | $14M | $13M | $13M | $13M | $14M | $14M | $14M | $14M | $14M | $14M | $15M | |
| Financing Cash Flow | $-189M | $-222M | $-296M | $-135M | $-228M | $-91M | $-427M | $-90M | $-420M | $-209M | $-182M | $18M | $-224M | $-106M | $-15M | $-179M | |
| Net Change in Cash | $20M | $-19M | $55M | $-25M | $18M | $-1M | $20M | $-19M | $17M | $-8M | $34M | $1M | $-30M | $8M | $35M | $-37M | |
| Taxes Paid | $189M | $8M | $115M | $104M | $246M | $6M | $88M | $105M | $129M | $3M | $67M | $57M | $131M | $2M | $69M | $37M | |
| Free Cash Flow | · | $184M | · | · | · | $121M | · | · | · | $188M | · | · | · | $122M | · | · | |
| Levered FCF | · | $156M | · | · | · | $90M | · | · | · | $146M | · | · | · | $83M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 11.2% | · | 11.6% | 11.7% | 11.1% | · | 9.7% | 11.2% | 10.1% | · | 8.0% | 7.9% | 8.0% | · | 8.3% | |
| Net Margin | 7.7% | 7.8% | · | 8.3% | 8.2% | 7.7% | · | 6.5% | 7.4% | 6.8% | · | 4.7% | 4.8% | 4.7% | · | 5.5% | |
| Pretax Margin | 10.3% | 10.4% | · | 11.1% | 11.1% | 10.3% | · | 8.6% | 9.8% | 8.7% | · | 6.2% | 6.3% | 6.2% | · | 7.0% | |
| EBITDA Margin | 11.1% | 11.2% | · | 11.6% | 11.7% | 11.1% | · | 9.7% | 11.2% | 10.1% | · | 8.0% | 7.9% | 8.0% | · | 8.3% | |
| ROA | 2.3% | 2.3% | · | 2.5% | 2.4% | 2.2% | · | 1.8% | 2.1% | 1.9% | · | 1.2% | 1.3% | 1.2% | · | 1.4% | |
| ROE | 4.9% | 4.9% | · | 5.4% | 5.2% | 4.9% | · | 4.1% | 4.6% | 4.3% | · | 2.8% | 2.9% | 2.8% | · | 3.0% | |
| ROIC | 3.2% | 3.2% | · | 3.4% | 3.3% | 3.0% | · | 2.7% | 3.0% | 2.8% | · | 2.0% | 1.9% | 1.9% | · | 2.0% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 1.0 | 1.3 | 1.3 | · | 1.4 | 1.3 | 1.4 | · | 1.4 | 1.3 | 1.4 | · | 1.3 | |
| Quick Ratio | 0.9 | 0.9 | · | 0.9 | 1.1 | 1.1 | · | 1.2 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.1 | · | 1.0 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Interest Coverage | 12.9 | 13.5 | · | 13.6 | 14.1 | 11.4 | · | 8.6 | 8.9 | 7.4 | · | 5.3 | 5.7 | 5.5 | · | 7.7 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.9 | 1.7 | · | 1.8 | 1.8 | 1.8 | · | 1.7 | 1.8 | 1.8 | · | 1.8 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $77.42 | $72.89 | · | $70.61 | $65.91 | $62.08 | · | $58.19 | $57.53 | $56.13 | · | $51.17 | $50.09 | $48.51 | · | $45.66 | |
| Cash Flow / Share | · | $6.51 | · | · | · | $5.45 | · | · | · | $5.79 | · | · | · | $4.07 | · | · | |
| Dividend Paid / Share | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | |
| EPS (TTM) | $24.50 | $23.95 | · | $21.03 | $18.97 | $17.80 | · | $15.01 | $13.61 | $11.77 | · | $9.52 | $9.62 | $9.40 | · | $9.72 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18.11B | $17.76B | · | $16.99B | $16.46B | $16.08B | · | $15.42B | $15.02B | $14.66B | · | $14.03B | $13.80B | $13.57B | · | $13.23B | |
| Net Income TTM | $1.53B | $1.52B | · | $1.38B | $1.26B | $1.20B | · | $1.03B | $934M | $817M | · | $676M | $692M | $685M | · | $740M | |
| P/E | 6.1 | 7.5 | · | 9.7 | 9.5 | 10.6 | · | 15.3 | 13.6 | 15.5 | · | 13.2 | 16.4 | 13.5 | · | 9.1 | |
| Earnings Yield | 16.5% | 13.4% | · | 10.3% | 10.5% | 9.5% | · | 6.6% | 7.4% | 6.5% | · | 7.6% | 6.1% | 7.4% | · | 11.0% | |
| Payout Ratio | · | 3.7% | · | · | · | 4.3% | · | · | · | 5.2% | · | · | · | 8.7% | · | · | |
| Annual Payout | $50M | $51M | · | $52M | $53M | $53M | · | $54M | $54M | $55M | · | $56M | $57M | $58M | · | $60M |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Gelir | $17.36B | $15.83B | $14.28B | · | · |
| Faaliyet Kâr Marjı % | 11.5% | 10.6% | 8.2% | · | · |
| Net Gelir | $1.49B | $1.14B | $718M | · | · |
| Seyreltilmiş Hisse Başı Kâr | $23.10 | $16.82 | $10.23 | · | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.7 | 0.7 | 0.8 | · | · |
| Cari Oran | 1.1 | 1.3 | 1.4 | · | · |
| Cari Oran | 0.8 | 1.0 | 1.2 | · | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $849M | $1.12B | $525M | · | · |
Kurumsal Sahipler (13F) 641 dosya · $9.0B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 73 (-10 önceki Ç'ye göre) | 122 (+33 önceki Ç'ye göre) | 215 (-37 önceki Ç'ye göre) | 240 (+8 önceki Ç'ye göre) | +2.4M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1.414.195.886 | 6.486.542 | 15,65% | Hisse senetleri |
| First Eagle Investment Management, LLC | $677.233.918 | 4.554.670 | 7,49% | Hisse senetleri |
| BlackRock, Inc. | $603.655.463 | 4.059.826 | 6,68% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $504.386.069 | 3.392.199 | 5,58% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $364.614.198 | 2.452.177 | 4,03% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $328.686.665 | 2.210.595 | 3,64% | Hisse senetleri |
| STATE STREET CORP | $312.637.527 | 2.102.613 | 3,46% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $293.152.556 | 1.974.065 | 3,24% | Hisse senetleri |
| PZENA INVESTMENT MANAGEMENT LLC | $292.819.232 | 1.969.327 | 3,24% | Hisse senetleri |
| Invesco Ltd. | $290.116.048 | 1.951.147 | 3,21% | Hisse senetleri |
| FMR LLC | $210.657.318 | 1.416.755 | 2,33% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $210.522.439 | 1.415.848 | 2,33% | Hisse senetleri |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $158.819.352 | 1.068.124 | 1,76% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $140.451.548 | 944.592 | 1,55% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $135.479.763 | 906.103 | 1,50% | Hisse senetleri |
| NORGES BANK | $132.110.916 | 888.499 | 1,46% | Hisse senetleri |
| MORGAN STANLEY | $111.481.141 | 749.754 | 1,23% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $89.504.438 | 601.953 | 0,99% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $85.524.258 | 575.185 | 0,95% | Hisse senetleri |
| CANADA PENSION PLAN INVESTMENT BOARD | $83.716.782 | 563.029 | 0,93% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $76.891.019 | 523.210 | 0,85% | Hisse senetleri |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $75.911.300 | 510.534 | 0,84% | Hisse senetleri |
| NORTHERN TRUST CORP | $67.032.574 | 450.821 | 0,74% | Hisse senetleri |
| Invenomic Capital Management LP | $63.529.884 | 427.264 | 0,70% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $62.058.597 | 417.369 | 0,69% | Hisse senetleri |
| Qube Research & Technologies Ltd | $59.094.313 | 397.433 | 0,65% | Hisse senetleri |
| MACKENZIE FINANCIAL CORP | $56.636.764 | 380.905 | 0,63% | Hisse senetleri |
| Ranmore Fund Management Ltd | $56.501.159 | 379.993 | 0,63% | Hisse senetleri |
| Allianz Asset Management GmbH | $56.202.738 | 377.986 | 0,62% | Hisse senetleri |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $52.580.501 | 353.625 | 0,58% | Hisse senetleri |
| UBS Group AG | $49.695.321 | 334.221 | 0,55% | Hisse senetleri |
| CITADEL ADVISORS LLC | $45.818.377 | 308.147 | 0,51% | Hisse senetleri |
| Quantinno Capital Management LP | $45.782.797 | 307.907 | 0,51% | Hisse senetleri |
| Bank of New York Mellon Corp | $44.605.741 | 299.992 | 0,49% | Hisse senetleri |
| NORDEA INVESTMENT MANAGEMENT AB | $44.371.846 | 300.663 | 0,49% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $44.081.678 | 296.467 | 0,49% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $42.437.187 | 237.119 | 0,47% | Hisse senetleri |
| Khrom Capital Management LLC | $39.401.958 | 264.994 | 0,44% | Hisse senetleri |
| Russell Investments Group, Ltd. | $37.642.835 | 253.289 | 0,42% | Hisse senetleri |
| Bridgewater Associates, LP | $33.919.311 | 228.121 | 0,38% | Hisse senetleri |
| SEI INVESTMENTS CO | $33.100.670 | 222.614 | 0,37% | Hisse senetleri |
| MOORE CAPITAL MANAGEMENT, LP | $33.071.927 | 222.422 | 0,37% | Hisse senetleri |
| Allspring Global Investments Holdings, LLC | $32.949.468 | 218.817 | 0,36% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $31.202.151 | 209.847 | 0,35% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $31.057.609 | 208.876 | 0,34% | Hisse senetleri |
| CARRONADE CAPITAL MANAGEMENT, LP | $29.738.000 | 200.000 | 0,33% | Hisse senetleri |
| JPMORGAN CHASE & CO | $29.603.947 | 198.975 | 0,33% | Hisse senetleri |
| Arbejdsmarkedets Tillaegspension | $28.712.039 | 193.100 | 0,32% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $28.049.718 | 188.646 | 0,31% | Hisse senetleri |
| BARCLAYS PLC | $27.758.340 | 186.686 | 0,31% | Hisse senetleri |
Şirket yöneticileri 24 içeriden öğrenenler · 10 yöneticiler · 16 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Marc D Miller | President and CEO | 26 Mart 2026 A | 388.621 | 0 | 0 | $0 |
| Steve Filton | Executive Vice President & CFO | 26 Mart 2026 A | 144.715 | 0 | 0 | $0 |
| Alan B Miller | Executive Chairman | 27 Mayıs 2026 J | 25.495 | 0 | 0 | $0 |
| Edward H Sim | Executive Vice President | 26 Mart 2026 A | 24.790 | 0 | 0 | $0 |
| Matthew Jay Peterson | Executive Vice President, UHS | 26 Mart 2026 A | 31.984 | 0 | 0 | $0 |
| Marvin G. Pember | Executive Vice President | 23 Mart 2022 A | 36.599 | 0 | 0 | $0 |
| Debra K Osteen | Executive Vice President | 13 Nisan 2018 A | 93.174 | 0 | 0 | $0 |
| Richard C Wright | Vice President | 26 Kasım 2012 S | 0 | 0 | 0 | $0 |
| Michael Marquez | Senior Vice President | 04 Haziran 2010 M | 28.525 | 0 | 0 | $0 |
| Kevin J Gross | Senior Vice President | 31 Mayıs 2007 M | 623 | 0 | 0 | $0 |
| Nina Chen-Langenmayr | Yönetim kurulu üyesi | 20 Mayıs 2026 A | 4.267 | 0 | 0 | $0 |
| Maria Ruderman Singer | Yönetim kurulu üyesi | 20 Mayıs 2026 A | 9.792 | 0 | 0 | $0 |
| Warren J. Nimetz | Yönetim kurulu üyesi | 20 Mayıs 2026 A | 9.698 | 0 | 2 | $-852.356 |
| Eileen C. Mcdonnell | Yönetim kurulu üyesi | 20 Mayıs 2026 A | 9.406 | 0 | 0 | $0 |
| Elliot J Md Mba Sussman | Yönetim kurulu üyesi | 20 Mayıs 2026 A | 7.330 | 0 | 3 | $-345.899 |
| Lawrence S. Gibbs | Yönetim kurulu üyesi | 07 Mart 2023 S | 2.230 | 0 | 0 | $0 |
| Robert H Hotz | Yönetim kurulu üyesi | 29 Temmuz 2019 M | 52.715 | 0 | 0 | $0 |
| John H Herrell | Yönetim kurulu üyesi | 15 Mayıs 2018 M | 19.274 | 0 | 0 | $0 |
| Anthony Pantaleoni | Yönetim kurulu üyesi | 29 Kasım 2017 M | 1.794 | 0 | 0 | $0 |
| Leatrice Ducat | Yönetim kurulu üyesi | 05 Mart 2013 M | 4.000 | 0 | 0 | $0 |
| Richard J Santorum | Yönetim kurulu üyesi | 16 Mayıs 2011 M | 7.437 | 0 | 0 | $0 |
| Daniel B. Silvers | Yönetim kurulu üyesi | 03 Mayıs 2011 M | 2.048 | 0 | 0 | $0 |
| John F Williams JR | Yönetim kurulu üyesi | 21 Kasım 2008 A | 3.975 | 0 | 0 | $0 |
| Robert A Meister | Yönetim kurulu üyesi | 21 Kasım 2007 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 104 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| FXH · First Trust Exchange-Traded AlphaDE… | 2,57% | 159.598 NS | 31 Temmuz 2026 | N-PORT |
| LYLD · Cambria ETF Trust | 2,14% | 922 NS | 31 Temmuz 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,62% | 81.159 SH | 01 Ekim 2026 | Günlük |
| CVSM · Elevation Series Trust | 1,59% | 8.938 NS | 31 Temmuz 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,51% | 176.878 SH | 01 Ekim 2026 | Günlük |
| IHF · iShares Trust | 1,35% | 102.351 SH | 11 Eylül 2026 | Günlük |
| RNIN · EA Series Trust | 1,29% | 13.918 NS | 31 Temmuz 2026 | N-PORT |
| SYLD · Cambria ETF Trust | 1,09% | 64.307 NS | 31 Temmuz 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,04% | 13.049 NS | 31 Temmuz 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 0,95% | 15.263 NS | 31 Temmuz 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,80% | 10.896 NS | 31 Temmuz 2026 | N-PORT |
| FDRR · FIDELITY COVINGTON TRUST | 0,54% | 23.720 NS | 31 Temmuz 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,49% | 43.874 NS | 31 Temmuz 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,44% | 41.492 SH | 01 Ekim 2026 | Günlük |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,42% | 34.637 NS | 31 Temmuz 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,40% | 345.907 NS | 31 Temmuz 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,31% | 29.932 SH | 01 Ekim 2026 | Günlük |
| DFSV · Dimensional ETF Trust | 0,31% | 151.188 NS | 31 Temmuz 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,28% | 7.534 NS | 31 Temmuz 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,27% | 7.517 NS | 31 Temmuz 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,24% | 2.408 NS | 31 Temmuz 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 1.112.873 SH | 01 Ekim 2026 | Günlük |
| BKMC · BNY Mellon ETF Trust | 0,20% | 7.667 NS | 31 Temmuz 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,19% | 5.968.000 | 01 Ekim 2026 | Günlük |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 22.463 NS | 31 Temmuz 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,18% | 27.092 NS | 31 Temmuz 2026 | N-PORT |
| FDVV · FIDELITY COVINGTON TRUST | 0,18% | 107.089 NS | 31 Temmuz 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,16% | 737.146 SH | 19 Ağustos 2026 | Günlük |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,16% | 220.000 | 01 Ekim 2026 | Günlük |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 7.588 NS | 31 Temmuz 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,15% | 8.469 SH | 19 Ağustos 2026 | Günlük |
| IYH · iShares Trust | 0,14% | 29.765 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 24.277 NS | 31 Temmuz 2026 | N-PORT |
| SMMD · iShares Trust | 0,12% | 27.226 SH | 11 Eylül 2026 | Günlük |
| LGDX · Tidal Trust III | 0,12% | 1.016 NS | 31 Temmuz 2026 | N-PORT |
| IXJ · iShares Trust | 0,12% | 28.234 SH | 11 Eylül 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,12% | 105.486 NS | 31 Temmuz 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,11% | 3.422.000 | 30 Eylül 2026 | Günlük |
| NFRA · FlexShares Trust | 0,11% | 20.262 NS | 31 Temmuz 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,11% | 153.595 SH | 19 Ağustos 2026 | Günlük |
| GLOF · iShares Trust | 0,11% | 1.247 SH | 11 Eylül 2026 | Günlük |
| CURE · Direxion Shares ETF Trust | 0,10% | 1.049 NS | 31 Temmuz 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 4.369 SH | 01 Ekim 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,09% | 3.027 NS | 31 Temmuz 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,09% | 51.375 SH | 01 Ekim 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1.161.113 SH | 19 Ağustos 2026 | Günlük |
| IWS · iShares Trust | 0,09% | 75.629 SH | 11 Eylül 2026 | Günlük |
| WSML · iShares Trust | 0,08% | 3.240 SH | 11 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,08% | 9.796 NS | 31 Temmuz 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,07% | 4.075 SH | 01 Ekim 2026 | Günlük |
| RECS · Columbia ETF Trust I | 0,07% | 25.532 NS | 31 Temmuz 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 208.577 SH | 11 Eylül 2026 | Günlük |
| DFUV · Dimensional ETF Trust | 0,06% | 53.251 NS | 31 Temmuz 2026 | N-PORT |
| XOEF · iShares Trust | 0,05% | 67 SH | 11 Eylül 2026 | Günlük |
| PRF · Invesco Exchange-Traded Fund Trust | 0,05% | 28.658 SH | 01 Ekim 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,04% | 107.516 NS | 31 Temmuz 2026 | N-PORT |
| IVE · iShares Trust | 0,03% | 88.425 SH | 11 Eylül 2026 | Günlük |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,03% | 12.323 SH | 19 Ağustos 2026 | Günlük |
| IUSV · iShares Trust | 0,03% | 46.100 SH | 11 Eylül 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,03% | 5.685 NS | 31 Temmuz 2026 | N-PORT |
| IWD · iShares Trust | 0,02% | 112.974 SH | 11 Eylül 2026 | Günlük |
| EGLE · Global X Funds | 0,02% | 3 NS | 31 Temmuz 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 30.745 SH | 19 Ağustos 2026 | Günlük |
| DYNF · BlackRock ETF Trust | 0,02% | 45.056 SH | 11 Eylül 2026 | Günlük |
| TOPC · iShares Trust | 0,02% | 33 SH | 11 Eylül 2026 | Günlük |
| XVV · iShares Trust | 0,02% | 647 SH | 11 Eylül 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,02% | 11.778 NS | 31 Temmuz 2026 | N-PORT |
| XYLG · Global X Funds | 0,02% | 58 NS | 31 Temmuz 2026 | N-PORT |
| XYLD · Global X Funds | 0,02% | 2.904 NS | 31 Temmuz 2026 | N-PORT |
| XRMI · Global X Funds | 0,01% | 44 NS | 31 Temmuz 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,01% | 2.808 NS | 31 Temmuz 2026 | N-PORT |
| XCLR · Global X Funds | 0,01% | 3 NS | 31 Temmuz 2026 | N-PORT |
| IVV · iShares Trust | 0,01% | 671.648 SH | 11 Eylül 2026 | Günlük |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 308 SH | 01 Ekim 2026 | Günlük |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 3.737 SH | 01 Ekim 2026 | Günlük |
| IWB · iShares Trust | 0,01% | 36.488 SH | 11 Eylül 2026 | Günlük |
| IYY · iShares Trust | 0,01% | 2.238 SH | 11 Eylül 2026 | Günlük |
| SPUU · Direxion Shares ETF Trust | 0,01% | 201 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 14.744 SH | 11 Eylül 2026 | Günlük |
| QDPL · Pacer Funds Trust | 0,01% | 1.283 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 68.363 SH | 11 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,01% | 14.968 NS | 31 Temmuz 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 42 SH | 01 Ekim 2026 | Günlük |
| HCMT · Direxion Shares ETF Trust | 0,01% | 369 NS | 31 Temmuz 2026 | N-PORT |
| XTR · Global X Funds | 0,01% | 3 NS | 31 Temmuz 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,01% | 4.165 NS | 31 Temmuz 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,01% | 1.383.774 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1.606.967 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 41.234 SH | 19 Ağustos 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 8.402 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 4.280 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,01% | 11.510 SH | 19 Ağustos 2026 | Günlük |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,01% | 879 SH | 01 Ekim 2026 | Günlük |
| DFLV · Dimensional ETF Trust | 0,00% | 636 NS | 31 Temmuz 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 3.000 | 30 Eylül 2026 | Günlük |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Temmuz 2026 | Günlük |
| ISCB · iShares Trust | · | 2.307 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 11.393 SH | 11 Eylül 2026 | Günlük |
| SMMV · iShares Trust | · | 2.436 SH | 01 Eylül 2026 | Günlük |
UHS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
12 Aylık Fiyat Hedefi
17 analist · 2026-09-27Ortalama hedef $194.35 +10,6%
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| UHS | · | 9.4 | 9.7% | 8.6% | 21.4% | · |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | · |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | · |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | · |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | · |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | · |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | · |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.